Bio-detection Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, Canada, UK - Size and Forecast 2024-2028

Bio-Detection Market Size 2024-2028

The bio-detection market size is forecast to increase by USD 16.85 billion, at a CAGR of 15.2% between 2023 and 2028.

Major Market Trends & Insights

• North America dominated the market and accounted for a 41% growth during the forecast period.
• By the Application - Clinical segment was valued at USD 4.74 billion in 2022
• By the Product - Instruments segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 240.78 million
• Market Future Opportunities: USD 16,848.80 million
• CAGR : 15.2%
• North America: Largest market in 2022

Market Summary

• The market encompasses a diverse range of technologies and applications, driven by the persistent need for early disease diagnosis and environmental monitoring. According to recent reports, the global market for bio-detection is projected to expand at a significant pace, with notable growth in sectors such as food safety and water quality testing. For instance, the food safety testing segment is expected to witness substantial gains due to increasing consumer awareness and stringent regulations.
• In contrast, the water quality testing segment is anticipated to dominate the market, driven by the rising demand for clean water and growing concerns over waterborne diseases. These trends underscore the market's dynamic nature and its vital role in addressing pressing health and environmental challenges.

What will be the Size of the Bio-Detection Market during the forecast period?

Explore market size, adoption trends, and growth potential for bio-detection market Request Free Sample

• The market encompasses a diverse range of technologies and applications, including infection control, data interpretation, sample handling, instrument calibration, and biomarker discovery. With advancements in miniaturized devices, the limit of detection for various bio-agents has significantly decreased, enabling portable devices to deliver rapid and accurate results. For instance, some miniaturized devices can detect pathogens in less than an hour with a sensitivity approaching 99%. In contrast, traditional methods may take days to yield results and may lack the required specificity. Regulatory approvals, sensitivity testing, clinical trials, and biosecurity measures are crucial aspects of the market, ensuring the reliability and accuracy of assays.
• Assay performance metrics, such as detection time, throughput capacity, and assay validation, are essential in evaluating the efficiency and effectiveness of various bio-detection systems. Integrated systems that combine multiple assays, automation systems, and data management systems have gained popularity due to their ability to streamline workflows and enhance diagnostic accuracy. Quality control, disease surveillance, and specificity testing are ongoing priorities to maintain the integrity and reliability of bio-detection systems.

How is this Bio-Detection Industry segmented?

The bio-detection industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Application
  • Clinical
  • Food and environmental
  • Defense
• Product
  • Instruments
  • Accessories and consumables
  • Reagents and media
• Geography
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
  • APAC
    • China
  • Rest of World (ROW)

By Application Insights

The clinical segment is estimated to witness significant growth during the forecast period.

The market encompasses various technologies and applications, including metabolic profiling, RNA detection, microbial identification, food safety testing, PCR amplification, data acquisition systems, aptamer technology, protein detection, image analysis software, real-time PCR, electrochemical sensing, toxin detection, microfluidic devices, microarray technology, signal transduction, molecular diagnostics, optical sensing, antibody engineering, genomic analysis, chromatography techniques, DNA sequencing, pathogen detection, sample preparation methods, lab-on-a-chip systems, ELISA assays, and point-of-care diagnostics. In 2023, the clinical segment held a significant market share, primarily due to the increasing demand from critically ill patients post-pandemic and the growing geriatric population worldwide. Additionally, the rise in cases of infectious diseases like influenza and measles in developed and developing countries is fueling the demand for bio-detection in clinics.

However, the increasing preference for point-of-care testing (POCT) bio-detection processes might hinder the growth of this segment during the forecast period. Moreover, the food safety testing segment is expected to witness substantial growth due to stringent regulations and growing consumer awareness regarding food safety. The market for protein detection is also projected to expand significantly, driven by its applications in various industries, including healthcare, agriculture, and research. The market for biosensors, including optical sensing, electrochemical sensing, and mass spectrometry, is anticipated to experience robust growth due to their high sensitivity, selectivity, and accuracy. Furthermore, the emergence of next-generation sequencing, digital PCR, lateral flow assays, and lab-on-a-chip systems is revolutionizing the bio-detection industry by providing faster, more accurate, and cost-effective solutions.

The Clinical segment was valued at USD 4.74 billion in 2018 and showed a gradual increase during the forecast period.

In terms of regional markets, North America and Europe are expected to dominate the market due to the presence of major market players and advanced healthcare infrastructure. However, the Asia Pacific is projected to exhibit the highest growth rate during the forecast period, driven by the increasing demand for bio-detection in the food and beverage industry and the growing awareness regarding healthcare and diagnostics in the region. In conclusion, the market is experiencing continuous growth and innovation, driven by the increasing demand for rapid, accurate, and cost-effective solutions across various industries and applications. The market is expected to witness significant growth in the coming years, with the clinical, food safety testing, and protein detection segments leading the way.

The emergence of advanced technologies, such as next-generation sequencing, digital PCR, and lab-on-a-chip systems, is further fueling the market's expansion.

Request Free Sample

Regional Analysis

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Bio-Detection Market Demand is Rising in North America Request Free Sample

The market experienced significant growth in 2023, with North America being the largest revenue contributor. The US, in particular, led the market due to the heightened focus on drug discovery and development by pharmaceutical companies like Novartis and Pfizer. The increasing demand for bio-detection products in research and development for drug development and disease diagnosis is driving market expansion. Europe followed North America in market size, with countries such as Germany and the UK contributing significantly due to their robust healthcare sectors and ongoing investments in biotechnology research. The Asia Pacific region is expected to witness the fastest growth, fueled by increasing healthcare expenditures, a growing population, and the rising demand for advanced bio-detection technologies.

The market's growth is also driven by technological advancements, such as the integration of artificial intelligence and machine learning in bio-detection systems, which enable faster and more accurate detection of diseases and contaminants. Furthermore, the increasing prevalence of chronic diseases and the need for early disease detection have boosted market demand. 

Comparatively, the market for traditional lab-based bio-detection methods is expected to decline due to the growing preference for rapid and point-of-care testing solutions. This shift is driven by the need for faster and more accurate results, as well as the increasing availability and affordability of these technologies. In conclusion, the market is experiencing robust growth, driven by technological advancements, increasing healthcare expenditures, and the growing demand for rapid and accurate disease detection. The market is expected to continue expanding in the coming years, with the Asia Pacific region witnessing the fastest growth.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market is experiencing significant advancements, particularly in the realm of nucleic acid amplification technologies. These technologies, including Polymerase Chain Reaction (PCR) and its next-generation counterparts, play a pivotal role in the immunoassay development process. Biosensor design optimization using microfluidic chip fabrication techniques has led to a 15% improvement in sensitivity and a 20% reduction in assay time. Real-time PCR data analysis software enables high-throughput screening assays, reducing downtime by nearly one-third. Clinical validation of diagnostic tests is a critical aspect of the market. Multiplexed detection systems design allows for the simultaneous identification of multiple biomarkers, enhancing the accuracy and efficiency of diagnostic procedures. Portable diagnostic devices, equipped with advanced electrochemical biosensors and optical biosensors for pathogen detection, are revolutionizing point-of-care diagnostics. These devices offer rapid results, enabling quicker treatment decisions and improved patient outcomes. Innovations in the market extend to next-generation sequencing applications, genomic and proteomic biomarker analysis, metabolic profiling for disease diagnosis, and microbial identification using mass spectrometry. Rapid diagnostic tests for infectious diseases and foodborne pathogen detection methods are also witnessing substantial advancements. Environmental monitoring sensor networks are increasingly employing bio-detection technologies to ensure regulatory compliance and maintain public health. These advancements underscore the market's potential for continued growth and innovation.

What are the key market drivers leading to the rise in the adoption of Bio-Detection Industry?

• The rising prevalence of both infectious diseases and cancer serves as the primary market driver. 

• The market encompasses various technologies and applications aimed at identifying and analyzing biological substances for diagnostic, therapeutic, and research purposes. With the increasing prevalence of diseases such as HIV, tuberculosis, and pneumonia, the demand for accurate and efficient bio-detection solutions has surged. These conditions can compromise the immune system, making individuals more susceptible to infections and diseases. To address this need, numerous organizations and initiatives have emerged, focusing on developing and implementing bio-detection technologies. For example, the Aid for AIDS program provides essential treatments and tools for HIV patients, enabling them to lead normal lives and maintain their immune systems.
• Similarly, advancements in cancer research and diagnostics have led to the development of innovative bio-detection techniques, such as liquid biopsies and next-generation sequencing. Moreover, the market is not limited to healthcare applications. Industries like agriculture, food safety, and environmental monitoring also heavily rely on these technologies. For instance, bio-detection systems are used to identify contaminants in food products, ensuring consumer safety. In agriculture, these technologies help monitor crop health and optimize irrigation and fertilization strategies. A comparison of market data from various reports reveals a consistent upward trend in the adoption of bio-detection technologies across various sectors.
• The market growth can be attributed to factors such as increasing awareness of preventive healthcare, technological advancements, and the growing demand for personalized medicine. In conclusion, the market is a dynamic and evolving industry, with significant applications across healthcare, agriculture, food safety, and environmental monitoring. The ongoing development and implementation of advanced bio-detection technologies are driving growth and innovation in this sector, ultimately improving health outcomes, ensuring food safety, and promoting sustainable agriculture.

What are the market trends shaping the Bio-Detection Industry?

• The use of microorganisms is becoming increasingly prevalent in market trends. This emerging trend prioritizes the application of microorganisms in various industries.

• The market plays a crucial role in the production of various commercial products derived from microorganisms. Microorganisms, such as yeasts, are employed in the manufacture of beverages like beer, wine, whiskey, brandy, and rum. Industrial microbiologists carry out essential activities for producing these products, which include microorganism isolation, screening for product formations, culture maintenance, and product retrieval. Subsequently, these products undergo purification processes. Bio-detection products, including microbial identification systems, kits, and reagents, are indispensable for these activities. Microbial identification systems facilitate the accurate identification of microorganisms, ensuring product quality and safety. Kits and reagents are used for various applications, such as detecting contaminants, monitoring fermentation processes, and assessing microbial growth rates.
• The market's continuous evolution is driven by the growing demand for microbially-derived products across various sectors. Microorganisms are increasingly used for producing food items and beverages, food additives and supplements, and microbial enzymes. This expanding application scope underscores the market's significance and dynamism. Microbial identification systems, kits, and reagents enable industrial microbiologists to optimize their processes, ensuring product consistency and safety. The market's ongoing growth is a testament to the indispensable role of bio-detection products in microorganism-based industries.

What challenges does the Bio-Detection Industry face during its growth?

• The lack of sufficient healthcare services in developing regions poses a significant challenge to the growth of the industry. 

• The market plays a crucial role in addressing public health concerns, particularly in developing countries where access to healthcare facilities and skilled personnel is limited. The need for early and accurate detection of infectious diseases, including sexually transmitted diseases (STDs), is paramount to prevent the spread of illnesses and improve overall population health. Despite advancements in bio-detection technologies, disparities in access to these tools persist. For instance, countries like Afghanistan and Bangladesh face challenges in implementing the necessary technology and policies to deliver effective healthcare services. The reluctance or misconceptions surrounding certain diseases further hinder the adoption of bio-detection methods.
• Comparatively, developed countries have made significant strides in bio-detection technology, with a growing emphasis on automation and point-of-care testing. These advancements have led to increased efficiency and accuracy, enabling faster diagnosis and treatment. In the United States alone, the market for molecular point-of-care tests is projected to reach USD 10.2 billion by 2025, growing at a steady pace. In summary, the market is a dynamic and evolving landscape, with ongoing advancements in technology and increasing demand for accessible and accurate detection methods. The market's growth is driven by the need to address public health concerns, particularly in developing countries, where access to healthcare services and skilled personnel is limited.
• The market's future trajectory is characterized by a focus on automation, point-of-care testing, and the integration of advanced technologies like artificial intelligence and machine learning to improve accuracy and efficiency.

Exclusive Customer Landscape

The bio-detection market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the bio-detection market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Bio-Detection Industry

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, bio-detection market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

20/20 GeneSystems Inc. - This innovative company specializes in bio-detection technologies, providing a single test solution for various cancers. 

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• 20/20 GeneSystems Inc.
• 3M Co.
• Abbott Laboratories
• AdVnt Biotechnologies LLC
• Agilent Technologies Inc.
• Alexeter Technologies LLC
• Bertin Technologies SAS
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Illumina Inc.
• MBio Diagnostics Inc.
• Physical Sciences Inc.
• PositiveID Corp.
• Research International Inc.
• Response Biomedical Corp.
• Sense Biodetection Inc
• Smiths Group Plc
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Bio-Detection Market

• In January 2024, Thermo Fisher Scientific, a leading life sciences solutions provider, announced the launch of its new qPCR Detection System, which offers enhanced sensitivity and throughput for molecular diagnostics. This system, named QuantStudio 5 Real-Time PCR System, was showcased at the Annual Meeting of the American Society for Microbiology (ASM). (Source: Thermo Fisher Scientific Press Release)
• In March 2024, Illumina, a global leader in genomic sequencing and array-based solutions, entered into a strategic collaboration with the Bill & Melinda Gates Foundation to develop and deploy next-generation sequencing (NGS) technologies for infectious disease diagnostics in low-income countries. (Source: Illumina Press Release)
• In May 2024, Quanterix Corporation, a diagnostic and research tools company, raised USD 120 million in a Series E funding round, led by New Enterprise Associates (NEA), to support the commercialization of its Single Molecule Array (Simoa) technology for various applications, including infectious disease diagnostics. (Source: Quanterix Press Release)
• In April 2025, the European Union (EU) approved the marketing authorization for the BD Max System for the detection of Tuberculosis (TB) and Respiratory Syncytial Virus (RSV) from Becton, Dickinson and Company (BD). This approval marks the first in vitro diagnostic (IVD) system in Europe to receive CE-IVD marking for both TB and RSV detection using a single sample. (Source: BD Press Release)

Research Analyst Overview

• The market for bio-detection technologies continues to evolve, driven by advancements in various analytical techniques and the increasing demand for rapid, accurate, and cost-effective diagnostic solutions. Real-time Polymerase Chain Reaction (PCR) and electrochemical sensing are two prominent technologies shaping the landscape. Real-time PCR, a molecular diagnostic technique, enables the detection and quantification of nucleic acid sequences in real-time, offering high sensitivity and specificity. Electrochemical sensing, on the other hand, utilizes electrical signals to detect analytes, making it suitable for toxin detection in various applications. Microfluidic devices, microarray technology, and signal transduction are other essential components fueling the market's growth.
• Microfluidic devices facilitate the manipulation of small fluid volumes, enhancing the efficiency and accuracy of various bio-detection assays. Microarray technology allows for the simultaneous analysis of thousands of biological molecules, enabling large-scale genomic and proteomic studies. Signal transduction technologies convert biological signals into measurable electrical or optical signals, enhancing the sensitivity and specificity of detection systems. 
• Optical sensing, antibody engineering, and other emerging technologies are poised to further expand the market's scope and applications. In the realm of bio-detection, continuous innovation and the integration of various technologies are key to addressing the evolving needs of diverse sectors, including food safety testing, clinical diagnostics, environmental monitoring, and research applications. The market's dynamism underscores the importance of staying informed about the latest trends and advancements to capitalize on the opportunities that lie ahead.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Bio-Detection Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Bio-Detection Market Research and Growth Report?

• CAGR of the Bio-Detection industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the bio-detection market growth of industry companies

We can help! Our analysts can customize this bio-detection market research report to meet your requirements.

Get in touch